Rubella Quant Ab. IgG

The Epstein-Barr Evaluation assesses several antibodies to the Epstein-Barr virus (EBV). It is performed to confirm active, past, or indeterminate infection for EBV-associated infectious mononucleosis.

This test measures IgG, IgA, and IgM antibodies to Candida albicans. Candida-specific antibodies can be significantly elevated in systemic candidiasis. These antibodies have been identified in healthy individuals while poor antibody response is observed in immunocompromised patients.

This test detects antibodies to the bacterium Borrelia burgdorferi. Lyme disease is caused by Borrelia burgdorferi and is transmitted to humans through the bite of infected black-legged ticks. Immunoblot testing will confirm a detected screening result.

This is a single-marker test measuring IgG antibodies to cytomegalovirus (CMV). A positive result may indicate exposure to CMV.

This panel is used to help diagnose hepatitis.